|
|
Volumn 26, Issue 6, 2002, Pages 492-496
|
|
Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients
|
|
Author keywords
Hemodialysis; Hepatitis B vaccination; Immune system; Levamisole
|
|
Indexed keywords
ANTIBODIES;
BODY FLUIDS;
HEMODIALYZERS;
IMMUNE SYSTEM;
PATIENT TREATMENT;
T-CELLS;
VACCINES;
VIRUSES;
ANTIBODIES RESPONSE;
GROUP 4;
HAEMODIALYSIS;
HEMODIALYSIS PATIENT;
HEPATITIS B;
HEPATITIS B VACCINATION;
HEPATITIS B VIRUS;
LEVAMISOLE;
MEAN AGES;
RESPONSE RATE;
DIALYSIS;
GEN HEVAC B PASTEUR;
HEPATITIS B ANTIBODY;
HEPATITIS B CORE ANTIBODY;
HEPATITIS B VACCINE;
LEVAMISOLE;
IMMUNOLOGICAL ADJUVANT;
ADULT;
AGED;
ANTIBODY BLOOD LEVEL;
ANTIBODY RESPONSE;
ARTICLE;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
FEMALE;
HEALTH PROGRAM;
HEMODIALYSIS;
HEMODIALYSIS PATIENT;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
IMMUNE RESPONSE;
IMMUNOMODULATION;
INFECTION PREVENTION;
INFECTION RISK;
LIVER PROTECTION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VACCINATION;
ADOLESCENT;
DRUG COMBINATION;
IMMUNOLOGY;
MIDDLE AGED;
PROSPECTIVE STUDY;
RENAL REPLACEMENT THERAPY;
RISK FACTOR;
HEPATITIS B VIRUS;
ADJUVANTS, IMMUNOLOGIC;
ADOLESCENT;
ADULT;
AGED;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPATITIS B;
HEPATITIS B ANTIBODIES;
HEPATITIS B VACCINES;
HUMANS;
LEVAMISOLE;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
RENAL DIALYSIS;
RISK FACTORS;
|
|
EID: 0036016581
PISSN: 0160564X
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1525-1594.2002.06928.x Document Type: Article |
|
Times cited : (41)
|
|
References (32)
|
